Zai Lab Ltd (ZLAB) is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite positive technical indicators like MACD and a slight pre-market price increase, the overbought RSI and lack of significant positive catalysts suggest caution. The financial performance shows revenue growth but declining net income and EPS, which raises concerns about profitability. Analyst ratings remain optimistic with 'Overweight' and 'Buy' ratings, but consistent price target reductions signal tempered expectations. Options data indicates bearish sentiment with a high Open Interest Put-Call Ratio. Without strong trading signals or news catalysts, it is better to hold and reassess later.
The MACD histogram is positive at 0.41 and expanding, indicating bullish momentum. RSI is at 86.642, signaling the stock is overbought. Moving averages are converging, suggesting indecision in price direction. Key resistance levels are R1: 23.226 and R2: 24.162, while support levels are S1: 20.192 and S2: 19.256.

MACD indicates bullish momentum. Pre-market price increased by 0.64%. Analyst ratings remain optimistic with 'Overweight' and 'Buy' ratings.
RSI indicates overbought conditions. Financial performance shows declining net income and EPS. Analysts have consistently lowered price targets. Options data suggests bearish sentiment with a high Open Interest Put-Call Ratio of 2.14.
In Q4 2025, revenue increased by 16.99% YoY to $127.6M. However, net income dropped by 38.29% YoY to -$50.4M, and EPS fell by 37.50% YoY to -0.05. Gross margin declined slightly to 60.08%, down 2.17% YoY.
Analysts maintain optimistic ratings ('Overweight' and 'Buy'), but price targets have been consistently lowered. The latest price targets range from $32 to $53, reflecting tempered expectations.